DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $118,415 | -20.4% | 13,216 | 0.0% | 0.04% | -12.5% |
Q2 2023 | $148,680 | -51.2% | 13,216 | -50.0% | 0.05% | -9.4% |
Q1 2023 | $304,496 | +97.2% | 26,432 | +98.3% | 0.05% | -3.6% |
Q4 2022 | $154,448 | -7.5% | 13,326 | +1.2% | 0.06% | -11.3% |
Q3 2022 | $167,000 | +83.5% | 13,168 | -0.2% | 0.06% | +87.9% |
Q2 2022 | $91,000 | -28.3% | 13,191 | 0.0% | 0.03% | -13.2% |
Q1 2022 | $127,000 | -15.3% | 13,191 | +4.2% | 0.04% | -9.5% |
Q4 2021 | $150,000 | -26.1% | 12,657 | +1.2% | 0.04% | -34.4% |
Q3 2021 | $203,000 | -22.8% | 12,513 | 0.0% | 0.06% | -16.9% |
Q2 2021 | $263,000 | +35.6% | 12,513 | 0.0% | 0.08% | +28.3% |
Q1 2021 | $194,000 | – | 12,513 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |